Global Bio-chem Technology Group Co. Ltd. (GLY0) Price & Analysis

0 Followers

GLY0 Stock Chart & Stats

€0.01

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€0.01

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€0.01 - €0.04

Previous CloseN/A

VolumeN/A

Average Volume (3M)0.00

Market Cap

€65.15M

Enterprise Value€4.29B

Total Cash (Recent Filing)€126.34M

Total Debt (Recent Filing)€1.86B

Price to Earnings (P/E)1.8

Beta-0.92

Next Earnings

Apr 01, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.20

Shares Outstanding1,683,277,100

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)-1.36

Price to Sales (P/S)0.31

P/FCF Ratio-24.77

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Diversified End-Market ExposureServing food, beverage, pharmaceutical, and industrial customers gives the company exposure to multiple demand pools. This breadth can reduce reliance on one end market and supports a durable platform for selling corn-derived ingredients across applications over the next several quarters.

Product Portfolio BreadthThe company participates across starch, modified starch, sweeteners, downstream ingredients and co-products. A broader corn-derived portfolio can support different customer needs, improve product-mix flexibility and create more opportunities to capture value beyond basic commodity processing.

Debt Reduction From Prior YearsDebt of roughly HK$1.8B in 2025 was materially lower than in prior years, indicating some deleveraging. If maintained, this reduction could ease refinancing pressure and improve financial flexibility, although negative equity still limits the benefit.

Bears Say

Negative Equity And High LeveragePersistent negative shareholders’ equity and large debt indicate structural balance-sheet weakness rather than a temporary setback. This reduces resilience, makes leverage metrics unfavorable, limits access to financial flexibility and leaves the company more exposed to refinancing pressure.

Weak And Unstable Cash GenerationNegative operating and free cash flow in 2025, alongside repeated weakness in earlier periods, shows that reported earnings have not consistently converted into cash. Unstable cash generation can constrain investment, debt service and working-capital funding over the next several quarters.

Falling Revenue And Weak Core ProfitabilityThe sharp 2025 revenue decline, thin gross margins and recurring negative EBIT point to weak underlying operating performance. This combination limits operating leverage, makes earnings less durable and increases dependence on an eventual recovery in sales or product mix.

Global Bio-chem Technology Group Co. Ltd. News

Global Bio-chem seals three-year corn supply and sales deals with major shareholder Nongfa

The latest announcement is out from Global Bio-chem Technology Group Co. Ltd. ( ($HK:0809) ). Global Bio-chem Technology...

7d ago

Global Bio-chem launches upgraded boilers and coenzyme Q10 expansion in Jilin

Global Bio-chem Technology Group Co. Ltd. ( ($HK:0809) ) has shared an announcement. Global Bio-chem Technology Group has...

2M ago

Global Bio-chem interim loss widens as margins collapse

The latest update is out from Global Bio-chem Technology Group Co. Ltd. ( ($HK:0809) ). Global Bio-chem Technology...

2M ago

Global Bio-chem announces sweeping board and management reshuffle

Global Bio-chem Technology Group Co. Ltd. ( ($HK:0809) ) has shared an update. Global Bio-chem Technology Group Company...

2M ago

Global Bio-chem Sets Out Board and Committee Structure

The latest announcement is out from Global Bio-chem Technology Group Co. Ltd. ( ($HK:0809) ). Global Bio-chem Technology...

2M ago

Global Bio-chem Sets Board Meeting to Review Interim Results and Possible Dividend

The latest update is out from Global Bio-chem Technology Group Co. Ltd. ( ($HK:0809) ). Global Bio-chem Technology...

2M ago

GLY0 FAQ

What was Global Bio-chem Technology Group Co. Ltd.’s price range in the past 12 months?

Global Bio-chem Technology Group Co. Ltd. lowest stock price was €0.01 and its highest was €0.04 in the past 12 months.

What is Global Bio-chem Technology Group Co. Ltd.’s market cap?

Global Bio-chem Technology Group Co. Ltd.’s market cap is €65.15M.

When is Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date?

Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date is Apr 01, 2027 which is in 156 days.

How were Global Bio-chem Technology Group Co. Ltd.’s earnings last quarter?

Global Bio-chem Technology Group Co. Ltd. released its earnings results on Aug 28, 2026. The company reported -€0.014 earnings per share for the quarter.

Is Global Bio-chem Technology Group Co. Ltd. overvalued?

According to Wall Street analysts Global Bio-chem Technology Group Co. Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Global Bio-chem Technology Group Co. Ltd. pay dividends?

Global Bio-chem Technology Group Co. Ltd. does not currently pay dividends.

What is Global Bio-chem Technology Group Co. Ltd.’s EPS estimate?

Global Bio-chem Technology Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Global Bio-chem Technology Group Co. Ltd. have?

Global Bio-chem Technology Group Co. Ltd. has 1,683,277,100 shares outstanding.

What happened to Global Bio-chem Technology Group Co. Ltd.’s price movement after its last earnings report?

Global Bio-chem Technology Group Co. Ltd. reported an EPS of -€0.014 in its last earnings report. Following the earnings report the stock price went down -3.125%.

Which hedge fund is a major shareholder of Global Bio-chem Technology Group Co. Ltd.?

Currently, no hedge funds are holding shares in DE:GLY0

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Global Bio-chem Technology Group Co. Ltd. Stock Smart Score

Underperform

Technicals

Fundamentals

Return on Equity

-15.63%

Trailing 12-Months

Asset Growth

4.04%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Global Bio-chem Technology Group Co. Ltd.

Global Bio-chem Technology Group Company Limited, an investment holding company, manufactures and sells corn refined products and corn-based biochemical products in the People's Republic of China, Asia, the Americas, and internationally. It operates through four segments: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company offers corn refined products, including corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meals, feed pellets, and corn germ cakes. It also provides downstream corn based biochemical products, such as amino acids comprising lysine, protein lysine, threonine, and glutamic acid; corn sweeteners, which include high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose; modified starches; and chemicals, such as ethylene, propylene, and butylene glycols, as well as resins. In addition, the company offers polyol chemicals, anti-freeze products, hydrogen, and ammonia. Its products are used in various applications, such as feed production, food and beverage, cosmetics, textiles, pharmaceuticals, chemical industries, etc. The company was founded in 1994 and is headquartered in Hung Hom, Hong Kong.